Your browser doesn't support javascript.
loading
In Vitro Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates of Gram-Negative Bacilli from 2018 to 2020: Results from the Global Evaluation of Antimicrobial Resistance via Surveillance (GEARS) Program.
Karlowsky, James A; Hackel, Meredith A; Wise, Mark G; Six, David A; Uehara, Tsuyoshi; Daigle, Denis M; Cusick, Susan M; Pevear, Daniel C; Moeck, Greg; Sahm, Daniel F.
Afiliação
  • Karlowsky JA; IHMA, Schaumburg, Illinois, USA.
  • Hackel MA; Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Wise MG; IHMA, Schaumburg, Illinois, USA.
  • Six DA; IHMA, Schaumburg, Illinois, USA.
  • Uehara T; Venatorx Pharmaceuticals, Inc., Malvern, Pennsylvania, USA.
  • Daigle DM; Venatorx Pharmaceuticals, Inc., Malvern, Pennsylvania, USA.
  • Cusick SM; Venatorx Pharmaceuticals, Inc., Malvern, Pennsylvania, USA.
  • Pevear DC; Venatorx Pharmaceuticals, Inc., Malvern, Pennsylvania, USA.
  • Moeck G; Venatorx Pharmaceuticals, Inc., Malvern, Pennsylvania, USA.
  • Sahm DF; Venatorx Pharmaceuticals, Inc., Malvern, Pennsylvania, USA.
Antimicrob Agents Chemother ; 67(1): e0128122, 2023 01 24.
Article em En | MEDLINE | ID: mdl-36541767
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana / Antibacterianos Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacorresistência Bacteriana / Antibacterianos Idioma: En Ano de publicação: 2023 Tipo de documento: Article